RicercaInizia una nuova ricerca
NOTA: è possibile cercare una corrispondenza esatta usando i doppi apici, ad es: "evoluzione della specie". Qualora si cerchi un identificativo, è consigliabile cercarlo in due modi differenti: tra apici con caratteri speciali es: "978-94-6366-274" oppure senza caratteri speciali solo come sequenza numerica: es 978946366274.
Polymorphism of interleukin-1B and development of gastric cancer: A metanalysis
2007 Vincenzi, B; Patti, G; Pantano, F; Venditti, O; Santini, D; Ruzzo, Annamaria; Schiavon, G; Graziano, F; Tonini, G.
BRAF V600E MUTATION AND AMPHIREGULIN (AR) IMMUNOHISTOCHEMICAL EXPRESSION IN THE PREDICTION OF BENEFIT FROM CETUXIMAB PLUS IRINOTECAN IN KRAS WILD-TYPE METASTATIC COLORECTAL CANCER (mCRC) PATIENTS
2009 Cremolini, C; Loupakis, F; Perrone, G; Ruzzo, Annamaria; Rulli, E; Garavaglia, D; Bencardino, K; Fornaro, L; Vincenzi, B; Stasi, I; Masi, G; Baldi, G; Floriani, I; Graziano, F; Falcone, A.
VEGF gene polymorphisms in the prediction of benefit from first-line FOLFIRI plus bevacizumab (BV) in metastatic colorectal cancer (mCRC) patients (pts)
2009 Loupakis, F; Ruzzo, A; Salvatore, L; Canestrari, E; Cremolini, C; Santini, D; Bencardino, K; Manzoni, M; Falcone, A; Graziano, F
PML AS A POTENTIAL PREDICTIVE FACTOR OF EFFICACY OF OXALIPLATIN BASED FIRST LINE CHEMOTHERAPY IN COLORECTAL CANCER PATIENTS
2009 Vincenzi, B; Perrone, G; Santini, D; Loupakis, F; Graziano, F; Ruzzo, Annamaria; Venditti, O; Onetti Muda, A; Falcone, A; Tonini, G.
BRAF V600E mutation and Amphiregulin (AR) immunohistochemical expression in the prediction of benefit from cetuximab plus irinotecan in KRAS wild-type metastatic colorectal cancer (mCRC) patients
2009 Cremolini, C; Loupakis, F; Perrone, G; Ruzzo, Annamaria; Rulli, E; Bencardino, K; Vincenzi, B; Salvatore, L; Graziano, F; Falcone, A.
EARLY MAGNESIUM MODIFICATIONS AS A SURROGATE MARKERS OF EFFICACY OF CETUXIMAB BASED ANTICANCER TREATMENT IN ADVANCED COLORECTAL CANCER PATIENTS
2010 Galluzzo, S; Vincenzi, B; Santini, D; Loupakis, F; Correale, ; Addeo, R; Graziano, F; Ruzzo, Annamaria; Falcone, A.; Tonini, G.
EARLY MAGNESIUM MODIFICATIONS AS A SURROGATE MARKERS OF EFFICACY OF CETUXIMAB BASED ANTICANCER TREATMENT IN ADVANCED COLORECTAL CANCER PATIENTS
2010 Vincenzi, B; Galluzzo, S; Santini, D; Loupakis, F; Correale, P; Addeo, R; Zoccoli, A; Graziano, F; Ruzzo, Annamaria; Del Prete, S; Falcone, A; Francini, G; Dicuonzo, G; Tonini, G.
HOST GENETIC VARIANTS IN THE INSULIN GROWTH FACTOR BINDING PROTEIN-3 IMPACT ON SURVIVAL OF PATIENTS WITH ADVANCED GASTRIC CANCER TREATED WITH PALLIATIVE CHEMOTHERAPY
2010 Catalano, V; Ruzzo, Annamaria; Canestrari, E; Santini, D; Galluccio, N; Loupakis, F; Alessandroni, P; Testa, E; Bisonni, R; D’Emidio, S; Angeletti, S; Tonini, G; Falcone, A; Magnani, Mauro; Graziano, F.
CETUXIMAB PLUS IRINOTECAN IN IRINOTECAN-RESISTANT ELDERLY METASTATIC COLORECTAL CANCER PATIENTS: CLINICAL OUTCOME ACCORDING TO KRAS AND BRAF MUTATIONAL STATUS
2010 Baldi, G; Fornaro, L; Masi, G; Vasile, E; Loupakis, F; Cupini, S; Allegrini, G; Marcucci, L; Stasi, I; Santini, D; Tonini, G; Graziano, F; Ruzzo, Annamaria; Magnani, Mauro; Falcone, A.
Let-7a microRNA levels in KRAS-mutated colorectal carcinomas determine survival differences in patients treated with anti-EGFR
2011 Canestrari, E; Ruzzo, Annamaria; Vincenzi, B; Galluccio, N; Perrone, G; Andreoni, Francesca; Lorenzini, P; Rulli, E; D'Emidio, S; Catalano, V; Loupakis, F; Bisonni, R; Floriani, I; De Nictolis, M; Santini, D; Salvatore, L; Tonini, G; Falcone, A; Magnani, Mauro; Graziano, F.
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Polymorphism of interleukin-1B and development of gastric cancer: A metanalysis | 1-gen-2007 | Vincenzi, B; Patti, G; Pantano, F; Venditti, O; Santini, D; Ruzzo, Annamaria; Schiavon, G; Graziano, F; Tonini, G. | |
| BRAF V600E MUTATION AND AMPHIREGULIN (AR) IMMUNOHISTOCHEMICAL EXPRESSION IN THE PREDICTION OF BENEFIT FROM CETUXIMAB PLUS IRINOTECAN IN KRAS WILD-TYPE METASTATIC COLORECTAL CANCER (mCRC) PATIENTS | 1-gen-2009 | Cremolini, C; Loupakis, F; Perrone, G; Ruzzo, Annamaria; Rulli, E; Garavaglia, D; Bencardino, K; Fornaro, L; Vincenzi, B; Stasi, I; Masi, G; Baldi, G; Floriani, I; Graziano, F; Falcone, A. | |
| VEGF gene polymorphisms in the prediction of benefit from first-line FOLFIRI plus bevacizumab (BV) in metastatic colorectal cancer (mCRC) patients (pts) | 1-gen-2009 | Loupakis, F; Ruzzo, A; Salvatore, L; Canestrari, E; Cremolini, C; Santini, D; Bencardino, K; Manzoni, M; Falcone, A; Graziano, F | |
| PML AS A POTENTIAL PREDICTIVE FACTOR OF EFFICACY OF OXALIPLATIN BASED FIRST LINE CHEMOTHERAPY IN COLORECTAL CANCER PATIENTS | 1-gen-2009 | Vincenzi, B; Perrone, G; Santini, D; Loupakis, F; Graziano, F; Ruzzo, Annamaria; Venditti, O; Onetti Muda, A; Falcone, A; Tonini, G. | |
| BRAF V600E mutation and Amphiregulin (AR) immunohistochemical expression in the prediction of benefit from cetuximab plus irinotecan in KRAS wild-type metastatic colorectal cancer (mCRC) patients | 1-gen-2009 | Cremolini, C; Loupakis, F; Perrone, G; Ruzzo, Annamaria; Rulli, E; Bencardino, K; Vincenzi, B; Salvatore, L; Graziano, F; Falcone, A. | |
| EARLY MAGNESIUM MODIFICATIONS AS A SURROGATE MARKERS OF EFFICACY OF CETUXIMAB BASED ANTICANCER TREATMENT IN ADVANCED COLORECTAL CANCER PATIENTS | 1-gen-2010 | Galluzzo, S; Vincenzi, B; Santini, D; Loupakis, F; Correale, ; Addeo, R; Graziano, F; Ruzzo, Annamaria; Falcone, A.; Tonini, G. | |
| EARLY MAGNESIUM MODIFICATIONS AS A SURROGATE MARKERS OF EFFICACY OF CETUXIMAB BASED ANTICANCER TREATMENT IN ADVANCED COLORECTAL CANCER PATIENTS | 1-gen-2010 | Vincenzi, B; Galluzzo, S; Santini, D; Loupakis, F; Correale, P; Addeo, R; Zoccoli, A; Graziano, F; Ruzzo, Annamaria; Del Prete, S; Falcone, A; Francini, G; Dicuonzo, G; Tonini, G. | |
| HOST GENETIC VARIANTS IN THE INSULIN GROWTH FACTOR BINDING PROTEIN-3 IMPACT ON SURVIVAL OF PATIENTS WITH ADVANCED GASTRIC CANCER TREATED WITH PALLIATIVE CHEMOTHERAPY | 1-gen-2010 | Catalano, V; Ruzzo, Annamaria; Canestrari, E; Santini, D; Galluccio, N; Loupakis, F; Alessandroni, P; Testa, E; Bisonni, R; D’Emidio, S; Angeletti, S; Tonini, G; Falcone, A; Magnani, Mauro; Graziano, F. | |
| CETUXIMAB PLUS IRINOTECAN IN IRINOTECAN-RESISTANT ELDERLY METASTATIC COLORECTAL CANCER PATIENTS: CLINICAL OUTCOME ACCORDING TO KRAS AND BRAF MUTATIONAL STATUS | 1-gen-2010 | Baldi, G; Fornaro, L; Masi, G; Vasile, E; Loupakis, F; Cupini, S; Allegrini, G; Marcucci, L; Stasi, I; Santini, D; Tonini, G; Graziano, F; Ruzzo, Annamaria; Magnani, Mauro; Falcone, A. | |
| Let-7a microRNA levels in KRAS-mutated colorectal carcinomas determine survival differences in patients treated with anti-EGFR | 1-gen-2011 | Canestrari, E; Ruzzo, Annamaria; Vincenzi, B; Galluccio, N; Perrone, G; Andreoni, Francesca; Lorenzini, P; Rulli, E; D'Emidio, S; Catalano, V; Loupakis, F; Bisonni, R; Floriani, I; De Nictolis, M; Santini, D; Salvatore, L; Tonini, G; Falcone, A; Magnani, Mauro; Graziano, F. |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile
Opzioni
Scopri
Tipologia
- 4 Contributo Atto di Convegno (ex... 41
- 4 Contributo Atto di Convegno (ex... 41
Data di pubblicazione
- 2020 - 2021 2
- 2010 - 2019 24
- 2001 - 2009 15
Editore
- Il Pensiero Scientifico 2
- AMER SOC HEMATOLOGY, 2021 L ST NW... 1
- Il Pensiero Scientifico Editore 1
- Oxford University Press 1
- Wichtig Editore - Milano 1
Rivista
- ANNALS OF ONCOLOGY 18
- JOURNAL OF CLINICAL ONCOLOGY 8
- HAEMATOLOGICA 3
- TUMORI 3
- EUROPEAN JOURNAL OF CANCER. SUPPL... 2
- BLOOD 1
- EUROPEAN MEDICAL JOURNAL. HEMATOLOGY 1
- I SUPPLEMENTI DI TUMORI 1
- JOURNAL OF CLINICAL ONCOLOGY 1
- LEUKEMIA RESEARCH 1
Keyword
- 1. colorectal cancer 2. sex 3. ... 1
- cancer 1
- colon 1
- colon carcinoma 1
- polymorphisms 1
- WOS:000253322200050 1
Lingua
- eng 24
Accesso al fulltext
- no fulltext 41